| FDA to Disclose More Details on Drug, Food Safety The FDA would begin publicizing safety problems with the drugs and devices it rejects under a new proposal. online.wsj.com |
Arena Weight Loss Drug Looks Promising Wealth Daily submits:By Ian CooperWeight loss may not be the most exciting topic right now... But a lot of money is going to be made in the coming years on obesity drug stocks.Complete Story » seekingalpha.com |
Sequenom, Inc. Q2 2010 Earnings Call Transcript Sequenom, Inc. (SQNM)Q2 2010 Earnings Call TranscriptAugust 5, 2010 4:30 pm ETComplete Story » seekingalpha.com |
Dendreon Stays in Neutral Zacks.com submits: We are maintaining our Neutral recommendation on Dendreon Corporation (DNDN) with a target price of $44.00. Dendreon, founded in 1992 and headquartered in Seattle, Washington, is a biotechnology company focused on developing drugs for cancer. The company received a huge boost with the US Food and Drug Administration (FDA) approving Provenge (sipuleucel-T), a therapeutic vaccine for treating advanced prostate cancer in men.Complete Story » seekingalpha.com |
FDA Rejects Expansion Of ViroPharma Drug ViroPharma said U.S. drug regulators declined to approve an expansion of the company's manufacturing of the drug Cinryze, which treats a hereditary disease, as the agency asked for more information. online.wsj.com |